# **The Physics and Clinical Translation of Spiral and Dedicated Breast Computed Tomography: A Comprehensive Review of Technology, Quantitative Metrics, and Automated Analysis (2019–2025)**

## **1\. Introduction**

The detection and characterization of breast cancer have historically relied on the projection physics of mammography, a modality inherently limited by the superposition of three-dimensional (3D) anatomy onto a two-dimensional (2D) plane. This geometric limitation results in a "masking effect," where dense fibroglandular tissue obscures underlying malignancies, and "summation artifacts," where overlapping normal tissues mimic pathology. While Digital Breast Tomosynthesis (DBT) has mitigated these issues through pseudo-3D acquisition, it remains a limited-angle tomographic technique with anisotropic resolution (high in-plane, poor depth).

Dedicated Breast Computed Tomography (DBCT)—specifically the emergence of Spiral Breast CT (SBCT) utilizing Photon-Counting Detectors (PCD)—represents a fundamental shift in breast imaging physics. By providing fully isotropic, high-spatial-resolution 3D datasets without breast compression, DBCT offers a new landscape for quantitative imaging. For the medical physics community, this modality presents unique opportunities and challenges: optimizing dose efficiency through detector physics, exploiting quantitative Hounsfield Unit (HU) variances for non-contrast lesion discrimination, and developing automated computer-aided detection (CAD) systems capable of navigating massive volumetric datasets.

This report provides an exhaustive review of the technological evolution, diagnostic physics, and computational analysis of dedicated breast CT from 2019 to 2025\. It is designed to serve as a foundational literature review for research into automated tumor detection within this domain, highlighting the interplay between acquisition physics and algorithmic performance.

## ---

**2\. Dedicated Breast CT Technology Overview (2019–2025)**

The engineering landscape of dedicated breast CT has bifurcated into two distinct architectures: Cone-Beam Breast CT (CBBCT) using flat-panel detectors, and the more recently introduced Spiral Breast CT (SBCT) using photon-counting technology. Understanding the physical specifications of these systems is prerequisite to developing automated detection algorithms, as the image characteristics—noise power spectra, resolution, and artifact profiles—differ significantly.

### **2.1. System Architectures and Commercial Platforms**

#### **2.1.1. Cone-Beam Breast CT (CBBCT): The Koning Vera**

The Koning Vera Breast CT (formerly Koning Breast CT 1000\) represents the established standard in CBBCT technology and remains the only dedicated breast CT system with FDA Pre-Market Approval (PMA) in the United States.1

* **Acquisition Geometry:** The system employs a cone-beam geometry where the X-ray source and a large-area Flat-Panel Detector (FPD) rotate 360 degrees around the pendent breast in a single gantry rotation. The scan is rapid, typically completing an acquisition in approximately 7 seconds.3  
* **Detector Physics:** The system utilizes a cesium iodide (CsI) scintillator-based energy-integrating detector. While robust, FPDs are susceptible to electronic noise, particularly at low flux levels, and suffer from lower geometric efficiency compared to direct-conversion detectors due to the need for optical isolation between pixels.  
* **Resolution and Voxel Characteristics:** The Koning Vera provides isotropic voxel resolution. In standard diagnostic mode, the voxel size is approximately **0.273 mm³**, while high-resolution modes can achieve **0.155 mm³**.4 This isotropy is a distinct advantage over DBT for volumetric analysis.  
* **Radiation Dose:** The system operates at dose levels comparable to diagnostic mammography. Reported mean glandular doses (MGD) typically range from 5 to 15 mGy, depending on breast size and composition, aligning with the Mammography Quality Standards Act (MQSA) limits for diagnostic workups.5  
* **Clinical Status:** Beyond the US, the system has regulatory clearance in Canada, Australia, Thailand, and Qatar.1 It has secured distinct CPT codes (Category III) in the US, facilitating its integration into clinical workflows for diagnostic problem-solving.7

#### **2.1.2. Spiral Breast CT (SBCT): The nu:view (AB-CT)**

The nu:view system (AB-CT – Advanced Breast-CT GmbH, Erlangen, Germany) signifies a departure from cone-beam acquisition, adopting a spiral (helical) scanning trajectory coupled with photon-counting technology. This system has received CE marking and is seeing increasing adoption across Europe.8

* **Acquisition Geometry:** Unlike the circular trajectory of CBBCT, the nu:view employs a spiral acquisition where the gantry rotates while translating relative to the breast. This geometry is inherently more robust against cone-beam artifacts (such as data incompleteness at the cone edges) and allows for the scanning of variable breast lengths with consistent image quality.10  
* **Detector Physics:** The nu:view is the world’s first breast CT to utilize a **single-photon-counting detector (PCD)** based on Cadmium Telluride (CdTe).8 This direct-conversion technology converts incident X-ray photons directly into hole-electron pairs, bypassing the intermediate conversion to visible light required by scintillators.  
* **Scan Parameters:** A full spiral scan requires 7 to 12 seconds, acquiring up to 2,000 projections per 360° rotation. The X-ray tube features a notably fine focal spot of 0.3–0.4 mm (IEC 60336), enabling high-resolution imaging.11  
* **Resolution:** The combination of the fine focal spot and the PCD allows for a native detector pixel size of **(0.1 mm)²**. Reconstructions typically yield isotropic voxel sizes of **(0.15 mm)³ (150 microns)**.12 This resolution is critical for the detection of microcalcifications, a task historically challenging for CT modalities.  
* **Radiation Dose:** The system is optimized for low-dose performance, delivering radiation levels equivalent to screening mammography (approximately 5–7 mGy) while providing full 3D information.8

### **2.2. The Physics of Photon-Counting Detectors (PCD) in Breast CT**

For researchers developing automated detection algorithms, the transition from Energy-Integrating Detectors (EIDs) to PCDs in breast CT is significant. The physical properties of the detector fundamentally alter the noise texture and contrast resolution of the input data.

#### **2.2.1. Electronic Noise Elimination and CNR Improvement**

Conventional EIDs integrate all signals over a readout period, meaning electronic noise (dark current) is summed with the signal. In low-signal environments—such as imaging thick, dense breasts—this noise can degrade the Contrast-to-Noise Ratio (CNR). PCDs operate by counting individual photon events that trigger a pulse height exceeding a pre-set threshold. By setting this lower energy threshold above the electronic noise floor, PCDs effectively reject electronic noise entirely.15

* **Implication for Automated Detection:** The resulting images exhibit a different noise distribution compared to FPD-based images (zero-mean electronic noise is absent). This results in higher CNR for low-contrast soft tissue lesions, potentially lowering the detection threshold for automated algorithms operating on non-contrast data.16

#### **2.2.2. Optimized Energy Weighting**

EIDs are energy-integrating; a high-energy photon contributes more to the detector signal than a low-energy photon. However, in soft-tissue imaging, contrast is driven by the photoelectric effect, which is dominant at lower photon energies. Therefore, EIDs essentially down-weight the photons that carry the most contrast information. PCDs, by counting photons individually, assign equal weight to all photons (or can apply energy-optimized weighting). This "counter-weighting" significantly enhances the inherent contrast of soft tissue structures like glandular tissue and tumors.15

#### **2.2.3. Spatial Resolution and Geometric Efficiency**

PCDs utilize an electric field to steer the charge cloud created by an X-ray interaction directly to the pixel electrode. This eliminates the need for inter-pixel septa or reflectors used in scintillators to prevent light spread (optical crosstalk). Consequently, PCDs can achieve smaller pixel pitches (100 µm in nu:view) with high geometric dose efficiency.13

* **Relevance to Microcalcifications:** The detection of microcalcifications (typically 100–300 µm) relies heavily on high spatial frequencies. The Modulation Transfer Function (MTF) of PCD systems is superior to EID systems at these frequencies, enabling the visualization of calcification morphology critical for distinguishing benign from malignant etiology.14

### **2.3. Current Clinical Adoption Status**

The clinical integration of dedicated breast CT is in an expansion phase, transitioning from early adopters to broader clinical use.

* **United States:** The Koning Vera is the primary system, installed in specialized centers (e.g., Bedford Breast Center, Community Radiology NY). Adoption is driven by its diagnostic utility as an alternative to MRI for patients with implants or claustrophobia, and its FDA approval status.2  
* **Europe:** The AB-CT nu:view is seeing uptake in academic and private centers, particularly in Germany (e.g., University Hospital Erlangen, ARISTRA network) and Switzerland (University Hospital Zurich). It is frequently used for diagnostic workup of equivocal mammographic findings and screening in high-risk populations.9  
* **Regulatory Drivers:** The implementation of mandatory breast density reporting (e.g., FDA updates in 2024\) is increasing the demand for supplemental screening modalities. DBCT is positioned as a high-throughput, patient-friendly (no compression) alternative to breast MRI for women with dense breasts.19

## ---

**3\. Breast Density and Cancer Detection: Quantitative Physics**

One of the central arguments for the adoption of dedicated breast CT is the superior performance in dense breast tissue (BI-RADS C and D). The "masking effect" of mammography is a projection artifact; by resolving the breast in 3D, breast CT reduces this to a problem of intrinsic contrast resolution.

### **3.1. Breast CT vs. Mammography in Dense Breasts**

Comparing the diagnostic performance of breast CT against the gold standard (mammography) in dense breasts reveals distinct physics-based advantages.

* **Sensitivity in Dense Tissue:** Clinical studies indicate that while mammographic sensitivity declines significantly (to \<50%) in extremely dense breasts, breast CT maintains high sensitivity. In a study of women with personal histories of breast cancer, confidence in interpretation with breast CT was equal or superior to mammography in 98.4% of cases, primarily due to the elimination of superposition.14  
* **Contrast-Enhanced Performance:** When contrast media is employed (CE-BCT), the sensitivity in dense breasts approaches that of MRI (95-99%), significantly outperforming non-contrast mammography. Studies have shown CE-SBCT to have a diagnostic accuracy of 97.2% compared to 81.4% for mammography in comparable cohorts.14  
* **The Density Atlas:** Traditional BI-RADS density categories (A-D) are area-based assessments derived from 2D projections. Wieler et al. (2021) argued that this classification is insufficient for volumetric imaging. They proposed a new BCT-specific density classification based on "lesion detectability" and the 3D visibility of fatty septae. This suggests that automated density quantification algorithms for BCT should not merely mimic BI-RADS but quantify volumetric fibroglandular fractions.21

### **3.2. Quantitative Hounsfield Unit (HU) Analysis in Non-Contrast SBCT**

For automated tumor detection algorithms, the critical parameter in non-contrast imaging is the separability of tissue classes in feature space. The most fundamental feature is X-ray attenuation, measured in Hounsfield Units (HU).

Key Reference: Weber et al. (2024) 23 The study *"Potential of non-contrast spiral breast CT to exploit lesion density and favor breast cancer detection: A pilot study"* (European Journal of Radiology, 2024\) provides essential ground-truth data for physics-based feature engineering.

* **Methodology:** The study utilized the nu:view SBCT system (60 kV, 25 mA) to acquire non-contrast images of 40 women. Two readers measured the HU values of histologically proven lesions and normal structures.  
* **Quantitative Results:**  
  * **Malignant Lesions (ML):** Median density **60.2 HU** (Reader 1\) to **62.5 HU** (Reader 2).  
  * **Fibroadenomas (FA):** Median density **46.3 HU** (Reader 1\) to **44.5 HU** (Reader 2).  
  * **Cysts:** Median density **35.3 HU** (Reader 1\) to **39.7 HU** (Reader 2).  
  * **Extremely Dense Glandular Tissue (EDB):** Median density **28.7 HU** (Reader 1\) to **33.3 HU** (Reader 2).  
* **Physical Implications:**  
  * There is a statistically significant difference (p \< 0.001) between malignant lesions (\~61 HU) and the background dense glandular tissue (\~31 HU).  
  * This **\~30 HU contrast differential** confirms that malignant masses are hyperdense relative to even the densest normal parenchyma in non-contrast 60 kV scans.  
  * The separation between malignant lesions and cysts is also significant, aiding in the reduction of false positives, which is a common challenge in mass detection.  
* **Relevance to Automated Detection:** These values provide a robust physical basis for intensity-based thresholding or seeding in segmentation algorithms. An automated detector can exploit this hyperdensity, focusing sensitivity on regions \>50 HU, provided noise levels are sufficiently managed to prevent overlap between the Gaussian distributions of glandular tissue and tumor signal.

### **3.3. Sensitivity for Small Lesions (\<10mm)**

Detecting sub-centimeter lesions is the benchmark for screening efficacy.

* **The Resolution/Noise Trade-off:** In non-contrast CBBCT, detecting lesions \<10mm is limited by the similarity in attenuation between the lesion and glandular tissue (low CNR). However, the high spatial resolution of PCD-SBCT (150 µm) aids in identifying the *morphological* features (spiculation, irregular margins) of small masses that might otherwise be indistinguishable from focal glandular islands.25  
* **Contrast Enhancement:** When contrast is used, the detection of small lesions improves dramatically. Malignant lesions, even small ones, enhance significantly (mean enhancement \~55 HU) compared to benign tissues (\~17 HU).26 This enhancement kinetic allows for the detection of small invasive cancers that are mammographically occult.  
* **Microcalcifications:** Detection of microcalcification clusters (often the only sign of DCIS) requires high frequency spatial resolution. The PCD technology in nu:view has been shown to visualize microcalcifications with a conspicuity comparable to DBT, a significant advancement over earlier CBBCT generations.14

## ---

**4\. Automated Analysis and Artificial Intelligence on Dedicated Breast CT**

The volumetric nature of breast CT generates datasets comprising 500 to 2,000 slices per breast. Manual interpretation is time-prohibitive for screening workflows. Consequently, the development of automated analysis pipelines is a critical area of research. This section reviews methods specifically applied to *dedicated breast CT* data.

### **4.1. Automated Breast Tissue Segmentation**

Accurate segmentation of the breast organ—isolating it from the chest wall, pectoralis muscle, skin, and implants—is the necessary preprocessing step for any quantitative analysis or lesion detection pipeline.

Key Reference: Shim et al. (2022) 25 This study, *"Fully automated breast segmentation on spiral breast computed tomography images,"* published in the *Journal of Applied Clinical Medical Physics*, sets the standard for segmentation in SBCT.

* **Task:** Segmentation of adipose tissue, glandular tissue, skin, pectoralis muscle, and implants.  
* **Methodology:** The authors moved beyond simple thresholding (which fails due to noise and skin folds) and standard U-Nets. They implemented a hybrid framework:  
  1. **Heuristic Investigation:** Initial volume analysis to identify gross landmarks.  
  2. **Adaptive Seeded Watershed:** Used to separate the breast from the chest wall and pectoralis muscle, handling the variable boundary intensities.  
  3. **Region Growing:** Optimized for the specific noise texture of the PCD images to isolate the skin and implants.  
* **Results:** The method achieved Dice Similarity Coefficients (DSC) of **0.90–0.97** for overall breast segmentation compared to expert manual contouring.  
* **Relevance:** This robust segmentation allows for the calculation of *Volumetric Breast Density (VBD)*, a more physically accurate risk metric than the area-based BI-RADS density. It also defines the "search volume" for subsequent tumor detection algorithms, reducing false positives from the chest wall or skin.25

**Other Approaches:**

* **Caballo et al. (2018):** Developed an unsupervised algorithm using energy-minimizing splines and fuzzy C-means clustering for tissue classification in CBBCT. While effective for dosimetry simulations, it lacked the robustness of later DL methods for complex anatomies.27

### **4.2. Automated Lesion Detection (CADe) and Diagnosis (CADx)**

Detecting and classifying lesions in 3D is a complex computational challenge due to the high dimensionality of the data and the class imbalance (few lesion voxels vs. millions of normal voxels).

**Deep Learning Approaches:**

* Caballo et al. (2020) 28: Focused on mass segmentation using Deep Learning (U-Net architectures) in CBBCT.  
  * **Key Finding:** The study demonstrated that DL-based segmentation could generate radiomic features (shape, texture) that were statistically indistinguishable from those derived from expert radiologist contours. This validates the use of DL segmentation as a reliable proxy for human annotation in training downstream classification models.  
* Lyu et al. (2021/2023) 29: Addressed the computational cost of 3D processing.  
  * **Method:** Instead of feeding the entire 3D volume into a network, they utilized a **Multi-View Deep Learning** architecture. The algorithm extracted 2D patches from the 3D volume along various orthogonal planes (axial, sagittal, coronal).  
  * **Architecture:** A dual-stream network combining a **Convolutional Branch** (CNN) to learn feature representations from the image patches and a **Handcrafted Branch** (MLP) to process traditional radiomic features.  
  * **Results:** The hybrid system achieved an Area Under the Curve (AUC) of **0.947**, significantly outperforming three board-certified radiologists whose performance ranged from 0.814 to 0.902. This result underscores the potential of AI to augment human performance by integrating complex volumetric data that is difficult for humans to synthesize.29

**Feature Engineering and Radiomics:**

* Landsmann et al. (2022) 31: Investigated the utility of Texture Analysis (Radiomics) versus Convolutional Neural Networks (CNN) for density classification in SBCT.  
  * **Method:** Analyzed 10,000 images from the nu:view system.  
  * **Results:** The CNN achieved an accuracy of 85.5%, while logistic regression based on texture features (Skewness, Grey-Level Nonuniformity) achieved 80%.  
  * **Physics Insight:** The study noted that texture features like Skewness decreased linearly with increasing breast density. They argued that radiomics might capture subtle parenchymal patterns (like the "fatty septae" identified by Wieler et al.) more explicitly than black-box CNNs, offering interpretability for risk assessment models.

## ---

**5\. Comprehensive Literature Review Table**

The following table summarizes the key research papers relevant to automated detection in dedicated breast CT (2018–2025).

| Authors | Year | Journal | Breast CT System | Task | Method | Key Result | Relevance to Paper |
| :---- | :---- | :---- | :---- | :---- | :---- | :---- | :---- |
| **Weber et al.** 23 | 2024 | *European Journal of Radiology* | SBCT (nu:view) | HU Characterization | Quantitative analysis of HU values in non-contrast scans (n=40). | Malignant lesions (\~60-62 HU) are significantly denser than glandular tissue (\~28-33 HU) (p\<0.001). | Establishes the physical HU thresholds for automated detection without contrast. |
| **Shim et al.** 25 | 2022 | *J. Appl. Clin. Med. Phys.* | SBCT (nu:view) | Tissue Segmentation | Hybrid framework (Adaptive Watershed \+ Region Growing). | DSC of 0.90–0.97 for breast components; high agreement with manual segmentation. | Provides a validated preprocessing method to isolate the breast volume for analysis. |
| **Landsmann et al.** 31 | 2022 | *Euro. Radiology Exp.* | SBCT (nu:view) | Density Classification | Comparison of Texture Analysis (Radiomics) vs. Deep Learning (CNN). | CNN accuracy 85.5%; Texture Analysis 80%. Skewness strongly correlated with density. | Suggests texture features are robust predictors of density/risk in PCD-SBCT. |
| **Lyu et al.** 29 | 2021 | *Physics in Med. & Bio.* (context) | CBBCT (Prototype) | Lesion Classification (CADx) | Multi-view Deep Learning model (CNN \+ Handcrafted Radiomics). | AUC 0.947, significantly outperforming radiologists (AUC 0.81-0.90). | Demonstrates the superiority of hybrid AI models for 3D lesion classification. |
| **Wieler et al.** 22 | 2021 | *Medicine* | SBCT (nu:view) | Density Standards | Creation of a new 3D Density Atlas based on lesion detectability. | Proposed a 4-category scale based on 3D visibility of fatty septae. | Provides the ground truth definition for "density" in volumetric breast imaging. |
| **Caballo et al.** 28 | 2020 | *Computers in Bio. & Med.* | CBBCT (Dedicated) | Lesion Segmentation | Deep Learning (U-Net) vs. Radiologist manual contours. | DL segmentation produced radiomic features statistically equivalent to experts. | Validates AI segmentation as a reliable basis for quantitative feature extraction. |
| **Berger et al.** 32 | 2020 | *Investigative Radiology* | SBCT (nu:view) | Clinical Performance | Observational study of SBCT in patients with implants. | High image quality; artifacts from implants did not obscure surrounding tissue. | Relevant for ensuring AI models are robust to implant artifacts. |
| **Ruby et al.** 14 | 2020 | *Medicine* | SBCT (nu:view) | Diagnostic Accuracy | Comparison of CE-SBCT vs. Mammography (105 lesions). | CE-SBCT sensitivity 99.1% vs. Mammography \~83% in dense breasts. | Sets the high sensitivity benchmark that automated systems must aim to match. |
| **Caballo et al.** 27 | 2018 | *Medical Physics* | CBBCT | Tissue Classification | Unsupervised energy-minimizing splines \+ clustering. | Accurate classification of skin, fat, and glandular tissue for dosimetry. | A foundational non-DL segmentation method useful for baseline comparisons. |

## ---

**6\. Synthesis and Discussion**

### **6.1. The "Photon-Counting" Advantage in Automated Detection**

The shift to Photon-Counting Detectors (PCD) in SBCT is not merely a hardware upgrade; it fundamentally enhances the signal quality available for automated analysis.

1. **Noise Texture:** PCD images lack the correlated electronic noise typical of flat-panel detectors. This results in a "cleaner" Noise Power Spectrum (NPS), which benefits gradient-based segmentation methods (like the watershed transform used by Shim et al.) that rely on edge detection.  
2. **Spectral Potential:** Although current clinical outputs are largely single-energy, the underlying PCD physics allows for energy binning. Future AI models could utilize multi-channel inputs (e.g., low-energy vs. high-energy bins) to perform "virtual biopsy" characterization, distinguishing cysts from solid masses based on their spectral attenuation curves, potentially improving upon the HU differentiation noted by Weber et al.

### **6.2. Density, Masking, and the AI Solution**

While SBCT eliminates the *geometrical* masking of 2D mammography, "structural noise" (the texture of the dense tissue itself) remains a challenge for human observers.

* **The Weber Threshold:** The finding that malignant lesions (\~60 HU) are distinct from dense tissue (\~30 HU) provides a powerful heuristic. However, in the presence of noise or beam-hardening artifacts (cupping), these distributions can overlap.  
* **AI Robustness:** Deep Learning models, particularly those trained on high-resolution patches (Lyu et al.), can learn to distinguish the specific *morphological* signature of a tumor (spiculation, distortion) even when the *density* contrast is low. This suggests that a successful automated detection pipeline should combine **intensity-based candidate generation** (using Weber's thresholds) with **DL-based false positive reduction**.

### **6.3. Challenges and Future Outlook**

Despite the promise, the field faces the "Data Scarcity" bottleneck. Unlike mammography, where datasets like DDSM contain thousands of cases, dedicated breast CT datasets are small and institutional (e.g., n=40 in Weber et al., n=105 in Ruby et al.). This necessitates the use of **Transfer Learning** (using models pre-trained on other modalities) or **Data Augmentation** techniques to train robust AI models.

Furthermore, the integration of SBCT into screening (as suggested by its dose equivalence to mammography) will generate massive data volumes. Automated systems must evolve from "Second Readers" (CAD) to "Triage Engines" that can autonomously flag high-probability normal scans, allowing radiologists to focus on complex cases.

## **7\. Conclusion**

The technological maturation of Spiral Breast CT between 2019 and 2025 has established a robust platform for 3D breast cancer screening. The physics of photon-counting detectors has solved historical challenges regarding resolution and dose efficiency. Diagnostic physics research (Weber et al. 2024\) has confirmed that quantifiable density differences exist to support non-contrast lesion detection. Simultaneously, computational frameworks (Shim et al., Lyu et al.) have demonstrated that AI can effectively segment anatomy and classify lesions in this volumetric domain.

For the purpose of your research paper, the evidence suggests that an automated tumor detection system for SBCT should ideally leverage a hybrid approach: utilizing rigorous physical preprocessing (segmentation and HU normalization) to feed high-resolution Deep Learning models. Such a system would exploit the full potential of the isotropic, high-contrast data provided by modern photon-counting breast CT.

---

**References used:**.1

#### **Works cited**

1. Koning Vera Breast CT System, US \- Medical Device Network, accessed February 10, 2026, [https://www.medicaldevice-network.com/projects/koning-vera-breast-ct-system-us/](https://www.medicaldevice-network.com/projects/koning-vera-breast-ct-system-us/)  
2. How Groundbreaking Koning Vera Breast CT Detects Cancer \- Nice News, accessed February 10, 2026, [https://nicenews.com/health-and-wellness/koning-vera-breast-ct-cancer-imaging-device/](https://nicenews.com/health-and-wellness/koning-vera-breast-ct-cancer-imaging-device/)  
3. Koning Health: Koning Breast CT | Improved Breast Imaging Technology, accessed February 10, 2026, [https://www.koninghealth.com/](https://www.koninghealth.com/)  
4. Koning KBCT Breast Imaging System Partial Specifications, accessed February 10, 2026, [https://www.koninghealth.com/pdfs/Koning\_%20Brochure.pdf](https://www.koninghealth.com/pdfs/Koning_%20Brochure.pdf)  
5. Koning Vera 3D Breast CT \- Convenzis, accessed February 10, 2026, [https://www.convenzis.co.uk/uploads/pdfs/02-EMG-koning-Brochure-68dfc83aca7fe.pdf](https://www.convenzis.co.uk/uploads/pdfs/02-EMG-koning-Brochure-68dfc83aca7fe.pdf)  
6. Topic Exploration Report 1 \- Health Technology Wales, accessed February 10, 2026, [https://healthtechnology.wales/wp-content/uploads/TER594-Cone-beam-breast-CT-WEB.pdf](https://healthtechnology.wales/wp-content/uploads/TER594-Cone-beam-breast-CT-WEB.pdf)  
7. Koning Breast CT \- MachineryHost, accessed February 10, 2026, [https://f.machineryhost.com/d397c2b2be2178fe6247bd50fc97cff2/cf001edf9c8dd51bc535f280f4a7784b/7838ddf8-61e1-4979-8272-a4b0b8ab1118\_1733861737227-KoningMarketingPPRev2%20(3).pdf](https://f.machineryhost.com/d397c2b2be2178fe6247bd50fc97cff2/cf001edf9c8dd51bc535f280f4a7784b/7838ddf8-61e1-4979-8272-a4b0b8ab1118_1733861737227-KoningMarketingPPRev2%20\(3\).pdf)  
8. nu:view \- JS Medical, accessed February 10, 2026, [https://medical.js-group.global/wp-content/uploads/2019/01/AB-CT-Brochure-2019.pdf](https://medical.js-group.global/wp-content/uploads/2019/01/AB-CT-Brochure-2019.pdf)  
9. Innovative breast diagnostics for women: Radiology network ARISTRA adopts AB-CT, accessed February 10, 2026, [https://ab-ct.com/innovative-breast-diagnostics-for-women-radiology-network-aristra-adopts-ab-ct-advanced-breast-cts-dedicated-breast-ct-technology/](https://ab-ct.com/innovative-breast-diagnostics-for-women-radiology-network-aristra-adopts-ab-ct-advanced-breast-cts-dedicated-breast-ct-technology/)  
10. What makes nu:view breast CT such a High Tech Device? \- Erlangen, Germany \- AB-CT, accessed February 10, 2026, [https://trends.medicalexpo.com/ab-ct-advanced-breast-ct/project-100517-444349.html](https://trends.medicalexpo.com/ab-ct-advanced-breast-ct/project-100517-444349.html)  
11. AB-CT NU:VIEW: Breast CT Scanner without Compression \- Examion.com, accessed February 10, 2026, [https://www.examion.com/en/products/ab-ct-nuview](https://www.examion.com/en/products/ab-ct-nuview)  
12. nu:view \- AB-CT – Advanced Breast-CT, accessed February 10, 2026, [https://ab-ct.com/nuview/](https://ab-ct.com/nuview/)  
13. an innovative technology for high resolution real 3D breast imaging without compression \- AB-CT, accessed February 10, 2026, [https://ab-ct.com/wp-content/uploads/2023/11/202003\_DIEurope\_AB-CT.pdf](https://ab-ct.com/wp-content/uploads/2023/11/202003_DIEurope_AB-CT.pdf)  
14. nu:view Breast CT | AB-CT, accessed February 10, 2026, [https://ab-ct.com/wp-content/uploads/2025/01/2025\_01\_09\_AB-CT\_Summary\_of\_relevant\_publications.pdf](https://ab-ct.com/wp-content/uploads/2025/01/2025_01_09_AB-CT_Summary_of_relevant_publications.pdf)  
15. Photon-counting detector CT: early clinical experience review | British Journal of Radiology | Oxford Academic, accessed February 10, 2026, [https://academic.oup.com/bjr/article/96/1147/20220544/7469214](https://academic.oup.com/bjr/article/96/1147/20220544/7469214)  
16. Photon-counting detector CT in oncology: a new era of cancer imaging \- PMC, accessed February 10, 2026, [https://pmc.ncbi.nlm.nih.gov/articles/PMC12824093/](https://pmc.ncbi.nlm.nih.gov/articles/PMC12824093/)  
17. A high-resolution photon-counting breast CT system with tensor-framelet based iterative image reconstruction for radiation dose reduction \- NIH, accessed February 10, 2026, [https://pmc.ncbi.nlm.nih.gov/articles/PMC5219880/](https://pmc.ncbi.nlm.nih.gov/articles/PMC5219880/)  
18. Koning Press Releases, accessed February 10, 2026, [https://www.koninghealth.com/index.php?option=com\_content\&view=category\&layout=blog\&id=81\&Itemid=755](https://www.koninghealth.com/index.php?option=com_content&view=category&layout=blog&id=81&Itemid=755)  
19. Breast Imaging for Screening and Diagnosing Cancer – Commercial and Individual Exchange Medical Policy \- UHC provider portal, accessed February 10, 2026, [https://www.uhcprovider.com/content/dam/provider/docs/public/policies/index/commercial/breast-imaging-screening-diagnosing-cancer-11012025.pdf](https://www.uhcprovider.com/content/dam/provider/docs/public/policies/index/commercial/breast-imaging-screening-diagnosing-cancer-11012025.pdf)  
20. The future of breast imaging: a date with density \- healthcare-in-europe.com, accessed February 10, 2026, [https://healthcare-in-europe.com/en/news/future-breast-imaging-density.html](https://healthcare-in-europe.com/en/news/future-breast-imaging-density.html)  
21. Breast density in dedicated breast computed tomography: Proposal of a classification system and interreader reliability \- PubMed, accessed February 10, 2026, [https://pubmed.ncbi.nlm.nih.gov/33950998/](https://pubmed.ncbi.nlm.nih.gov/33950998/)  
22. Detectability of Breast Cancer in Dedicated Breast CT Compared With Mammography Dependent on Breast Density | Request PDF \- ResearchGate, accessed February 10, 2026, [https://www.researchgate.net/publication/381915634\_Detectability\_of\_Breast\_Cancer\_in\_Dedicated\_Breast\_CT\_Compared\_With\_Mammography\_Dependent\_on\_Breast\_Density](https://www.researchgate.net/publication/381915634_Detectability_of_Breast_Cancer_in_Dedicated_Breast_CT_Compared_With_Mammography_Dependent_on_Breast_Density)  
23. Potential of non-contrast spiral breast CT to exploit lesion density ..., accessed February 10, 2026, [https://www.ejradiology.com/article/S0720-048X(24)00330-9/fulltext](https://www.ejradiology.com/article/S0720-048X\(24\)00330-9/fulltext)  
24. Potential of non-contrast spiral breast CT to exploit lesion density and favor breast cancer detection: A pilot study \- PubMed, accessed February 10, 2026, [https://pubmed.ncbi.nlm.nih.gov/39018650/](https://pubmed.ncbi.nlm.nih.gov/39018650/)  
25. J Applied Clin Med Phys \- 2022 \- Shim \- Fully Automated Breast Segmentation On Spiral Breast Computed Tomography Images \- Scribd, accessed February 10, 2026, [https://www.scribd.com/document/810635750/J-Applied-Clin-Med-Phys-2022-Shim-Fully-Automated-Breast-Segmentation-on-Spiral-Breast-Computed-Tomography-Images](https://www.scribd.com/document/810635750/J-Applied-Clin-Med-Phys-2022-Shim-Fully-Automated-Breast-Segmentation-on-Spiral-Breast-Computed-Tomography-Images)  
26. Contrast-enhanced Dedicated Breast CT: Initial Clinical Experience 1 \- RSNA Journals, accessed February 10, 2026, [https://pubs.rsna.org/doi/10.1148/radiol.10092311](https://pubs.rsna.org/doi/10.1148/radiol.10092311)  
27. An unsupervised automatic segmentation algorithm for breast tissue classification of dedicated breast computed tomography images \- PubMed, accessed February 10, 2026, [https://pubmed.ncbi.nlm.nih.gov/29676025/](https://pubmed.ncbi.nlm.nih.gov/29676025/)  
28. Deep learning-based segmentation of breast masses in dedicated breast CT imaging: Radiomic feature stability between radiologists and artificial intelligence \- PubMed, accessed February 10, 2026, [https://pubmed.ncbi.nlm.nih.gov/32174316/](https://pubmed.ncbi.nlm.nih.gov/32174316/)  
29. Computer-aided diagnosis of masses in breast computed ... \- NIH, accessed February 10, 2026, [https://pmc.ncbi.nlm.nih.gov/articles/PMC8005916/](https://pmc.ncbi.nlm.nih.gov/articles/PMC8005916/)  
30. Microcalcification detectability in breast CT images using CNN observers \- PMC \- NIH, accessed February 10, 2026, [https://pmc.ncbi.nlm.nih.gov/articles/PMC10922367/](https://pmc.ncbi.nlm.nih.gov/articles/PMC10922367/)  
31. (PDF) Applied Machine Learning in Spiral Breast-CT: Can We Train a Deep Convolutional Neural Network for Automatic, Standardized and Observer Independent Classification of Breast Density? \- ResearchGate, accessed February 10, 2026, [https://www.researchgate.net/publication/357818771\_Applied\_Machine\_Learning\_in\_Spiral\_Breast-CT\_Can\_We\_Train\_a\_Deep\_Convolutional\_Neural\_Network\_for\_Automatic\_Standardized\_and\_Observer\_Independent\_Classification\_of\_Breast\_Density](https://www.researchgate.net/publication/357818771_Applied_Machine_Learning_in_Spiral_Breast-CT_Can_We_Train_a_Deep_Convolutional_Neural_Network_for_Automatic_Standardized_and_Observer_Independent_Classification_of_Breast_Density)  
32. (PDF) Diagnostic value of a spiral breast computed tomography system equipped with photon counting detector technology in patients with implants: An observational study of our initial experiences \- ResearchGate, accessed February 10, 2026, [https://www.researchgate.net/publication/343191004\_Diagnostic\_value\_of\_a\_spiral\_breast\_computed\_tomography\_system\_equipped\_with\_photon\_counting\_detector\_technology\_in\_patients\_with\_implants\_An\_observational\_study\_of\_our\_initial\_experiences](https://www.researchgate.net/publication/343191004_Diagnostic_value_of_a_spiral_breast_computed_tomography_system_equipped_with_photon_counting_detector_technology_in_patients_with_implants_An_observational_study_of_our_initial_experiences)  
33. Koning Binder \- Jan 2023 \- Convenzis, accessed February 10, 2026, [https://www.convenzis.co.uk/uploads/pdfs/EMG-Koning-Binder-Jan-2023-68e37ec99d32f.pdf](https://www.convenzis.co.uk/uploads/pdfs/EMG-Koning-Binder-Jan-2023-68e37ec99d32f.pdf)